R Hawkins
Overview
Explore the profile of R Hawkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
159
Citations
1905
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hart J, Michael P, Hawkins R, Bull E, Farrar A, Baguley C, et al.
Br J Health Psychol
. 2023 Jul;
28(4):1206-1221.
PMID: 37455260
Introduction: In recent years, health psychology has received significant attention within the health sector, due to its application to understanding influences on health and well-being and translation of health psychology...
2.
Hawkins R, Shatil A, Lee L, Sengupta A, Zhang L, Morrow S, et al.
AJNR Am J Neuroradiol
. 2020 Feb;
41(3):449-455.
PMID: 32079601
Background And Purpose: Graph theory uses structural similarity to analyze cortical structural connectivity. We used a voxel-based definition of cortical covariance networks to quantify and assess the relationship of network...
3.
Pietsch E, Dong J, Cardoso R, Zhang X, Chin D, Hawkins R, et al.
Blood Cancer J
. 2017 Feb;
7(2):e536.
PMID: 28234345
CD47, a broadly expressed cell surface protein, inhibits cell phagocytosis via interaction with phagocyte-expressed SIRPα. A variety of hematological malignancies demonstrate elevated CD47 expression, suggesting that CD47 may mediate immune...
4.
Powles T, Brown J, Larkin J, Jones R, Ralph C, Hawkins R, et al.
Ann Oncol
. 2016 Jan;
27(5):880-6.
PMID: 26802156
Background: Preclinical work suggests SRC proteins have a role in the development of resistance to vascular endothelial growth factor (VEGF) targeted therapy in metastatic clear-cell renal cancer (mRCC). This hypothesis...
5.
Wagstaff J, Jones R, Hawkins R, Porfiri E, Pickering L, Bahl A, et al.
Ann Oncol
. 2015 Oct;
27(1):159-65.
PMID: 26489444
Background: The aim of the RECCORD registry was to gather real-world UK data on the use of targeted therapies in renal cell carcinoma (RCC) and assess clinical outcomes. Here, demographic...
6.
Beringer R, Guard B, Hawkins R, Segar P
Br J Anaesth
. 2015 Oct;
115(5):795-7.
PMID: 26475810
No abstract available.
7.
Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma
Dubois S, Allen S, Bent M, Hilton J, Hollinger F, Hawkins R, et al.
Br J Cancer
. 2015 Jan;
112(4):644-9.
PMID: 25602966
Background: (131)I-metaiodobenzylguanidine (MIBG) is an active radiopharmaceutical in neuroblastoma. A previous study demonstrated that MIBG could be combined with vincristine and prolonged irinotecan, although 25% of first courses had grade...
8.
Clarke D, Hawkins R, Sadler E, Harding G, McKevitt C, Godfrey M, et al.
BMJ Open
. 2014 Apr;
4(4):e004473.
PMID: 24736035
Objective: To evaluate the process of implementation of the modified London Stroke Carers Training Course (LSCTC) in the Training Caregivers After Stroke (TRACS) cluster randomised trial and contribute to the...
9.
Roy A, Cunningham D, Hawkins R, Sorbye H, Adenis A, Barcelo J, et al.
Br J Cancer
. 2012 Jul;
107(3):435-41.
PMID: 22767144
Background: Docetaxel and irinotecan chemotherapy have shown good efficacy in the treatment of advanced oesophago-gastric cancer. This randomised phase II study evaluated the efficacy and toxicity profile of two non-platinum...
10.
Porzig A, Matthay K, Dubois S, Pampaloni M, Damon L, Hawkins R, et al.
Horm Metab Res
. 2012 May;
44(7):539-42.
PMID: 22588707
Acute Respiratory Distress Syndrome (ARDS) has been reported rarely in pheochromocytoma, occurring spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG). Our objective was to determine whether proteinuria is associated with an...